HY2Care Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

HY2Care General Information

Description

Developer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel is composed of a mixture of natural polymer conjugates that cross-link via a mild enzymatic reaction, providing a scaffold for the patient's cells to regenerate cartilage, alleviate pain, and restore joint function, enabling clinicians to treat patients with functional repair of cartilage defects in the knee.

Contact Information

Website
www.hy2care.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands
Primary Industry
Therapeutic Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands

HY2Care Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HY2Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 29-May-2026 Completed Generating Revenue
12. Later Stage VC 14-May-2025 Completed Generating Revenue
11. Later Stage VC (Series A2) 23-Aug-2023 Completed Generating Revenue
10. Debt - General 12-Jan-2023 Completed Generating Revenue
9. Grant 23-Mar-2022 Completed Generating Revenue
8. Debt - General 27-Nov-2020 Completed Generating Revenue
7. Grant 07-Feb-2020 Completed Generating Revenue
6. Later Stage VC (Series A) 30-Apr-2019 Completed Generating Revenue
5. Debt - General 30-Apr-2019 $225K $241K Completed Generating Revenue
4. Angel (individual) 01-Jan-2017 $16.2K Completed Generating Revenue
To view HY2Care’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

HY2Care Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

HY2Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4403195-A1 Kit of parts suitable for preparing a biocompatible polymeric hydrogel Inactive 17-Jan-2023
EP-4651914-A1 Kit of parts suitable for preparing a biocompatible polymeric hydrogel Pending 17-Jan-2023
US-20260224781-A1 Kit of parts suitable for preparing a biocompatible polymeric hydrogel Pending 17-Jan-2023
WO-2024153601-A1 Kit of parts suitable for preparing a biocompatible polymeric hydrogel Inactive 17-Jan-2023
CA-3088978-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Pending 18-Jan-2018 C07K16/24
To view HY2Care’s complete patent history, request access »

HY2Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HY2Care Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Limburg Development and Investment Company Government Minority
European Innovation Council Accelerator/Incubator Minority
LifeSciences@Work Accelerator/Incubator
BVP (Brightlands Venture Partners) Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

HY2Care FAQs

  • When was HY2Care founded?

    HY2Care was founded in 2014.

  • Where is HY2Care headquartered?

    HY2Care is headquartered in Geleen, Netherlands.

  • What is the size of HY2Care?

    HY2Care has 12 total employees.

  • What industry is HY2Care in?

    HY2Care’s primary industry is Therapeutic Devices.

  • Is HY2Care a private or public company?

    HY2Care is a Private company.

  • What is HY2Care’s current revenue?

    The current revenue for HY2Care is .

  • How much funding has HY2Care raised over time?

    HY2Care has raised $15.4M.

  • Who are HY2Care’s investors?

    MedTech Innovator, Limburg Development and Investment Company, European Innovation Council, LifeSciences@Work, and BVP (Brightlands Venture Partners) are 5 of 9 investors who have invested in HY2Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process